About: Virus-induced exacerbations in asthma and COPD

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Virus-induced exacerbations in asthma and COPD Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Virus-induced exacerbations in asthma and COPD
Creator	Zhang, Wei Ishii, Haruyuki Kurai, Daisuke Saraya, Takeshi Takizawa, Hajime Sasaki, Shinichi
Source	Medline; PMC
abstract	Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation and/or airflow limitation due to pulmonary emphysema. Chronic bronchitis, pulmonary emphysema, and bronchial asthma may all be associated with airflow limitation; therefore, exacerbation of asthma may be associated with the pathophysiology of COPD. Furthermore, recent studies have suggested that the exacerbation of asthma, namely virus-induced asthma, may be associated with a wide variety of respiratory viruses. COPD and asthma have different underlying pathophysiological processes and thus require individual therapies. Exacerbation of both COPD and asthma, which are basically defined and diagnosed by clinical symptoms, is associated with a rapid decline in lung function and increased mortality. Similar pathogens, including human rhinovirus, respiratory syncytial virus, influenza virus, parainfluenza virus, and coronavirus, are also frequently detected during exacerbation of asthma and/or COPD. Immune response to respiratory viral infections, which may be related to the severity of exacerbation in each disease, varies in patients with both COPD and asthma. In this regard, it is crucial to recognize and understand both the similarities and differences of clinical features in patients with COPD and/or asthma associated with respiratory viral infections, especially in the exacerbative stage. In relation to definition, epidemiology, and pathophysiology, this review aims to summarize current knowledge concerning exacerbation of both COPD and asthma by focusing on the clinical significance of associated respiratory virus infections.
has issue date	2013-10-01(xsd:dateTime)
bibo:doi	10.3389/fmicb.2013.00293
bibo:pmid	24098299
has license	cc-by
sha1sum (hex)	8f9f22f0d245cf41e5047230fa1c907b47a734ac
schema:url	https://doi.org/10.3389/fmicb.2013.00293
resource representing a document's title	Virus-induced exacerbations in asthma and COPD
has PubMed Central identifier	PMC3787546
has PubMed identifier	24098299
schema:publication	Front Microbiol
resource representing a document's body	covid:8f9f22f0d245cf41e5047230fa1c907b47a734ac#body_text
is schema:about of	named entity 'VIRUS' named entity 'RESPIRATORY SYNCYTIAL VIRUS' named entity 'RECENT' named entity 'RELATED' named entity 'INFECTIONS' named entity 'PATIENTS' named entity 'FREQUENTLY' named entity 'REGARD' named entity 'IMMUNE RESPONSE' named entity 'HUMAN RHINOVIRUS' named entity 'RECOGNIZE' named entity 'ASTHMA' named entity 'AIMS' named entity 'SEVERITY' named entity 'UNDERLYING' named entity 'PATHOGENS' named entity 'DUE TO' named entity 'CHRONIC BRONCHITIS' named entity 'RESPONSE TO' named entity 'VIRAL INFECTIONS' named entity 'EXACERBATION OF ASTHMA' named entity 'LUNG FUNCTION' named entity 'PATHOPHYSIOLOGY' named entity 'processes' named entity 'similarities' named entity 'aims' named entity 'viruses' named entity 'recognize' named entity 'COPD' named entity 'COPD' named entity 'ASTHMA' named entity 'INDUCED' named entity 'CHRONIC AIRWAY INFLAMMATION' named entity 'CHRONIC OBSTRUCTIVE PULMONARY DISEASE' named entity 'THERAPIES' named entity 'INCREASED MORTALITY' named entity 'UNDERSTAND' named entity 'BRONCHIAL ASTHMA' named entity 'DEFINITION' named entity 'AIRFLOW LIMITATION' named entity 'RESPIRATORY' named entity 'WIDE' named entity 'PULMONARY EMPHYSEMA' named entity 'DIFFERENT' named entity 'DETECTED' named entity 'COPD' named entity 'SIMILAR' named entity 'EXACERBATION' named entity 'INDIVIDUAL' named entity 'EPIDEMIOLOGY' named entity 'VIRUS' named entity 'RELATION' named entity 'INDUCED' named entity 'VARIETY' named entity 'CLINICAL SYMPTOMS' named entity 'CLINICAL SIGNIFICANCE' named entity 'STUDIES' named entity 'CHARACTERIZED' named entity 'DISEASE' named entity 'CLINICAL FEATURES' named entity 'REVIEW' named entity 'CURRENT' named entity 'RAPID DECLINE' named entity 'PARAINFLUENZA VIRUS' named entity 'STAGE' named entity 'DEFINED' named entity 'ASSOCIATED WITH' named entity 'FOCUSING' named entity 'RESPIRATORY VIRUS' named entity 'DIAGNOSED' named entity 'INFLUENZA VIRUS' named entity 'RESPIRATORY VIRUSES' named entity 'ASSOCIATED' named entity 'KNOWLEDGE' named entity 'CORONAVIRUS' named entity 'HAVE'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software